Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2005-11-08
2005-11-08
Smith, Lynette R. F. (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S085100, C530S387100, C530S413000
Reexamination Certificate
active
06962700
ABSTRACT:
A method of manufacturing hymenoptera-immune globulin is disclosed. In a presently preferred embodiment, the method involves the steps of concentrating a raw immune globulin solution; freezing the concentrated immune globulin solution; thawing the frozen concentrated immune globulin solution; adding sufficient mono or disaccharide to the thawed concentrated immune globulin solution to yield a solution of about 0.25 to about 0.35 osmolar; filtering the thawed concentrated immune globulin solution; and lyophilizing the concentrated immune globulin solution.
REFERENCES:
patent: 4089944 (1978-05-01), Thomas
patent: 4186192 (1980-01-01), Lundblad et al.
patent: 4322403 (1982-03-01), Bünnig
patent: 4436724 (1984-03-01), Ohnishi
patent: 4482483 (1984-11-01), Curry et al.
patent: 4597966 (1986-07-01), Zolton et al.
patent: 4639513 (1987-01-01), Hou
patent: 4719290 (1988-01-01), Curry et al.
patent: 5177194 (1993-01-01), Sarno et al.
patent: 5346687 (1994-09-01), Rhodes
patent: 5563120 (1996-10-01), Kuznetsov
patent: 5908827 (1999-06-01), Sirna
patent: 6069236 (2000-05-01), Burnouf-Radosevich et al.
patent: 6165981 (2000-12-01), Flaa et al.
patent: 6281336 (2001-08-01), Laursen et al.
patent: 0205352 (1986-06-01), None
Harlow, Ed and Lane, David, Antibodies A Laboratory Manual, 1988, Cold Springs Harbor Laboratory, 287.
Cheung et al, (Annals of Allergy, vol. 50, Mar. , 1983, p. 155-160).
Bird et al, Journal of Immunological Methods, 71, 1984, 97-105.
Persson, Journal of Immunological Methods, 98, 91-19.
Lambin et al, Journal of Immunological Methods, 165, 1993, p. 99-111.
B.E. Garcia, Blocking Effect On The Release of Antigen-Specific Histamine, Journal of Investigational Allergology Clinical Immunology, vol. 3:1, pp. 26-33, Jan-Feb., 1993 (Abstract).
J. Bousquet, Combination of Passive and Active Immunization in Honeybee Venom Immunotherapy, Journal of Allergy and Clinical Immunology, vol. 79:6, pp. 947-54 (Abstract).
M.H. Lessof, Effects of Passive Antibody in Bee Venom Anaphylaxis, John Hopkins Medical Journal, vol. 142, pp. 107, Jan. 1978 (Abstract).
Lessof et al., “Effects of Passive Antibody in Been Venom Anaphylaxis,”The John Hopkins Med. J.142: 1-7 (1978).
Urbanek et al., “Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee strings and following termination of venom immunotherapy,”Clin. Allergy16: 317-322 (1986).
Lessof et al., “Protection against Anaphylaxis in Hymenoptera-Sensitive Patients by Passive Immunization,”Monogr. Allergy12: 253-256 (Karger, Basel 1977).
Aalberse et al., “Serologic Aspecs of IgG4 Antibodies,”J. of Immunol. 130(2): 722-723 (Feb. 1983).
Cheung et al., “Honey Bee Venom Specific Immunoglobulin G4 in Honey Bee String Allergic Patients and Bee Keepers,”Anls. Allergy50: 155-160 (Mar. 1983).
Schumacher et al., “Neutralization of Bee Venom Lethality by Immune Serum Antibodies,”Am. J. Trop. Med. Hyg. 55(2): 197-201 (1996).
Van Toorenenbergen, A.W. And Aalberse, R.C. “IgG4 and Passive Sensitization of Basophil Leukocytes,”Int. Archs Allergy Appl. Immun. 1981, pp. 432-440, vol. 65.
Atopix Pharmaceuticals Corporation
Ford Vanessa L.
Smith Lynette R. F.
LandOfFree
Method of manufacturing immune globulin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of manufacturing immune globulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of manufacturing immune globulin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3503958